Non-proliferative diabetic retinopathy
Showing 1 - 25 of >10,000
Dyslipidemia and Diabetic Retinopathy
Recruiting
- Diabetic Retinopathy
- Dyslipidemia
- 15 subjects with Non Proliferative Diabetic Retinopathy(mild, moderate and severe). 15 subjects with Proliferative Diabetic Retinopathy
- Healthy Controls 15 age matched control subjects
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Aug 11, 2022
Non Proliferative Diabetic Retinopathy(NPDR) Trial in Tianjin (pars plana vitrectomy(PPV), Pars plana vitrectomy(PPV)
Not yet recruiting
- Non Proliferative Diabetic Retinopathy(NPDR)
- pars plana vitrectomy(PPV)
- +2 more
-
Tianjin, ChinaTianjin medical university eye hospital
May 10, 2023
Non Proliferative Diabetic Retinopathy Trial in Seoul (Entelon Tab. 50mg, Placebo)
Recruiting
- Non Proliferative Diabetic Retinopathy
- Entelon Tab. 50mg
- Placebo
-
Seoul, Korea, Republic ofHallym University Kangnam Sacred Heart Hospital
Jul 19, 2022
Mild Non-proliferative Diabetic Retinopathy, Cataract Diabetic, Diabetic Retinopathy Trial in Shanghai (Ranibizumab Injection
Recruiting
- Mild Non-proliferative Diabetic Retinopathy
- +2 more
- Ranibizumab Injection [Lucentis]
- Phacoemulsification
-
Shanghai, Shanghai, ChinaDepartment of Ophthalmology, Ruijin Hospital Affiliated Medical,
May 18, 2022
Eyes With Non Proliferative Diabetic Retinopathy in Diabetes
Recruiting
- NPDR - Non Proliferative Diabetic Retinopathy
- +2 more
- Biomarkers
-
Dijon, France
- +4 more
Jul 18, 2022
Prophylactic PRP in Moderate NPDR
Completed
- Eye Diseases
- +2 more
- PRP
-
Assiut, EgyptAssiut University
Sep 14, 2022
Non-proliferative Diabetic Retinopathy Trial in United States (OPL-0401 Dose 1, OPL-0401 Dose 2, Placebo)
Recruiting
- Non-proliferative Diabetic Retinopathy
- OPL-0401 Dose 1
- +2 more
-
Mountain View, California
- +20 more
Dec 16, 2022
Non-Proliferative Diabetic Retinopathy Trial in Puerto Rico, United States (Faricimab)
Not yet recruiting
- Non-Proliferative Diabetic Retinopathy
-
Bakersfield, California
- +18 more
Jan 25, 2023
Type2 Diabetes, Diabetic Retinopathy Trial in China (Tangningtongluo tablets, Calcium dobesilate capsules)
Recruiting
- Type2 Diabetes
- Diabetic Retinopathy
- Tangningtongluo tablets
- Calcium dobesilate capsules
-
Chongqing, Chongqing, China
- +9 more
Jun 27, 2022
Anti-VEGF in Real-world
Recruiting
- Neovascular Age-related Macular Edema
- +5 more
- Ranibizumab
- +2 more
-
Beijing, Beijing, ChinaWen-Bin Wei
Feb 2, 2022
NPDR - Non Proliferative Diabetic Retinopathy Trial in Coimbra (Laboratory tests)
Completed
- NPDR - Non Proliferative Diabetic Retinopathy
- Laboratory tests
-
Coimbra, PortugalAIBILI- Association for Biomedical Research and Inovation on Lig
Oct 11, 2022
Non-proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy, Diabetic Macular Edema Trial in Riyadh (Bevacizumab)
Completed
- Non-proliferative Diabetic Retinopathy
- +2 more
-
Riyadh, Saudi ArabiaKing Khaled Eye Specialist Hospital
Dec 2, 2021
Non Proliferative Diabetic Retinopathy Trial in Guangzhou (Prompt panretinal photocoagulation, 25G Pars-plana vitrectomy)
Recruiting
- Non Proliferative Diabetic Retinopathy
- Prompt panretinal photocoagulation
- 25G Pars-plana vitrectomy
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Apr 20, 2021
Non-proliferative Diabetic Retinopathy Trial in Puerto Rico, United States (KSI-301, Sham injection)
Active, not recruiting
- Non-proliferative Diabetic Retinopathy
- KSI-301
- Sham injection
-
Phoenix, Arizona
- +46 more
Sep 22, 2022
Retinopathy, Diabetic Trial in Rochester (Aflibercept Injection, Sham injection)
Withdrawn
- Retinopathy, Diabetic
- Aflibercept Injection
- Sham injection
-
Rochester, New YorkFlaum Eye Institute, University of Rochester Medical Center
Apr 29, 2021
Diabetic Retinopathy Trial in United Kingdom (Fenofibrate 145 mg, Placebo Oral Tablet)
Active, not recruiting
- Diabetic Retinopathy
- Fenofibrate 145 mg
- Placebo Oral Tablet
-
Aberdeen, United Kingdom
- +15 more
Jun 8, 2022
Diabetic Macular Edema, Non-proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy Trial in Torrance
Completed
- Diabetic Macular Edema
- +2 more
- dexamethasone intravitreal implant
- intravitreal bevacizumab
-
Torrance, CaliforniaRetina Macula Institute
Mar 8, 2021
Diabetic Retinopathy, Sleep Apnea Trial in Madrid (device, drug, other)
Completed
- Diabetic Retinopathy
- Sleep Apnea
- Continuous positive airway pressure
- +2 more
-
Madrid, SpainHospital Universitario La Paz
May 10, 2021
Retinal Neurodegeneration In Type 2 Diabetes Mellitus Detected
Not yet recruiting
- Retinal Neuropathy
- Neurodegeneration
- Optical Coherence Tomography (OCT)
- (no location specified)
Mar 19, 2021
Specular Microscopy in Proliferative Diabetic Retinopathy
Not yet recruiting
- Corneal Endothelial Cell Changes in Diabetic Patients
- Specular microscopy
- (no location specified)
Apr 28, 2023
Proliferative Diabetic Retinopathy Trial in United States (Aflibercept)
Completed
- Proliferative Diabetic Retinopathy
-
Houston, Texas
- +3 more
May 20, 2021
Diabetic Retinopathy Trial in Worldwide (Runcaciguat (BAY1101042), Placebo)
Recruiting
- Diabetic Retinopathy
- Runcaciguat (BAY1101042)
- Placebo
-
Redlands, California
- +85 more
Jan 30, 2023
Non-proliferative Diabetic Retinopathy Trial (Intravitreal Bevacizumab IVB, Follow-up with regular examination for determination
Unknown status
- Non-proliferative Diabetic Retinopathy
- Intravitreal Bevacizumab IVB
- Follow-up with regular examination for determination of DR progression
- (no location specified)
Aug 12, 2020
Proliferative Diabetic Retinopathy, Vitreous Hemorrhage, Tractional Retinal Detachment Trial in Monastir (Bevacizumab Injection
Recruiting
- Proliferative Diabetic Retinopathy
- +2 more
- Bevacizumab Injection [Avastin]
- Peripheral Retinal Cryoapplication
-
Monastir, TunisiaFattouma Bourguiba University Hospital - Ophthalmology Departmen
Aug 22, 2022